Roche

The company sought to strengthen public and governmental awareness of breast cancer challenges in Russia, as well as to secure the position of its innovative cancer medicines in the healthcare system.

Client’s request:

Our results:

The medicines have been retained in the Essential Medicines List (EML).

01

Patient access to treatment has been granted.

02

The client’s market position in Russia has been secured.

03

Our solution

Key focus areas

01

We analyzed the regulatory risks arising from the reviewed circulation frameworks for cancer medicines, and proposed a position aligned with priorities set by public policy and pharmaceutical supply system.

Regulatory Risk Assessment and Positioning

03

A targeted GR campaign was designed and deployed to establish a meaningful dialogue with public authorities and promote the social significance of company’s innovative medicines.

Development and Implementation of Comprehensive GR Campaign

02

Key stakeholder mapping, including the Ministry of Health and the Government of the Russian Federation, research or expert organizations, and NGOs.

Stakeholder Mapping

back to cases and clients

Tags

Years: 2016

Industries: #Pharmaceuticals and medical devices #Healthcare

Stakeholders: #Ministry of Health of the Russian Federation #The Government of the Russian Federation#Research and expert organizations #NGOs

Our toolkit: : #Stakeholder mapping #GR communications #Pharmacoeconomics #Regulatory risk assessment #Data collection #Coalitions and alliances #Argumentation and positioning #Legal review #Lobbying #GR consulting #Organization of meetings